Scott Aaronson, MD
Enriched profileChief Science Officer, Institute for Advanced Diagnostics and Therapeutics at Sheppard Pratt Health System; Adjunct Professor, Department of Psychiatry, University of Maryland School of Medicine · University of Maryland School of Medicine
Scott Aaronson is Chief Science Officer, Institute for Advanced Diagnostics and Therapeutics at Sheppard Pratt Health System; Adjunct Professor, Department of Psychiatry, University of Maryland School of Medicine at University of Maryland School of Medicine. OpenAlex indexes 123 publications with 5,359 citations (h-index 33); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Scott Aaronson, M.D., is Chief Science Officer, Institute for Advanced Diagnostics and Therapeutics at Sheppard Pratt Health System at University of Maryland School of Medicine. The public record shows 123 publications with 5,359 citations (h-index 33), centered on Treatment of Major Depression, Electroconvulsive Therapy Studies, Transcranial Magnetic Stimulation Studies. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 7 companies.
- Most recent indexed publication: 2026 · The American journal of psychiatry
- Top research focus: Treatment of Major Depression
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 50.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sponsor: Sheppard Pratt Health System
- An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Sponsor: Sheppard Pratt Health System
- The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Sponsor: Sheppard Pratt Health System
Industry payments
Updated 18 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- LivaNova USA, Inc.Program year202530 payments$89,449openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
- Neurocrine BioSciences, Inc.Program year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
The American journal of psychiatry
Review2026 - The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
The British journal of psychiatry
Review2026 - A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
Psychedelic medicine (New Rochelle, N.Y.)
Article2025 - A retrospective analysis of bipolar depression treated with transcranial magnetic stimulation.
Brain and behavior
Article2020
Most-cited works
by citation count (OpenAlex)- 01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major DepressionArticle1,153 citations2022
- 02
- 03
- 04
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
psychiatrist.com/author/scott-t-aaronson
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatrist.com ↗
Mentions by others
where others cite or feature them- Other
sheppardpratt.org/research/our-researchers
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗ - Other
medschool.umaryland.edu/profiles/aaronson-scott
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗
- Psychiatry residency at McLean Hospital
Belmont, Massachusetts
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sheppardpratt.org ↗
Editorial & leadership roles
journal and society appointments- Distinguished Life Fellow
American Psychiatric Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗ - Fellow
American College of Psychiatrists
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗ - Board member
American Society for Clinical Psychopharmacology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗ - Board member
Clinical TMS Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗ - Fellow
Clinical TMS Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinicaltmssociety.org ↗ - Member
Advisory Board, Mind Medicine Australia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mindmedicineaustralia.org.au ↗ - Adjunct Professor
Department of Psychiatry, University of Maryland School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.umaryland.edu ↗
Awards & honors
honors on the public record- Fellow
American Society for Clinical Psychopharmacology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗
Secondary affiliations
appointments beyond the home institution- Chief Science Officer
Institute for Advanced Diagnostics and Therapeutics at Sheppard Pratt Health System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sheppardpratt.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Hochberg, MD
University of Maryland School of Medicine
Steven Kittner, MD, MPH
University of Maryland School of Medicine
Taofeek Owonikoko, MD
University of Maryland School of Medicine
Matthew Weir, MD
University of Maryland School of Medicine
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons